We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Gut Microbiome Analysis Identifies Frailty-Related Signatures in Older Adults

By LabMedica International staff writers
Posted on 14 Jul 2026

Frailty in older adults is marked by increased vulnerability to disease, falls, functional decline, and death, yet its biological drivers remain incompletely understood. More...

Because the gut microbiota influences multiple aspects of health and aging, investigators examined whether microbial composition and function reflect frailty status in late life. New findings show that reduced gut microbial diversity and functional capacity are associated with higher levels of frailty.

At the University of Gothenburg’s Sahlgrenska Academy, the team analyzed genetic material from the gut microbiota while assessing frailty with an internally developed and validated Frailty Mortality Index (FMI). The index integrates functional, physiological, and psychological dimensions associated with frailty and mortality risk. Microbial features evaluated included overall diversity, microbial gene counts, and predicted functional capacity.

The work draws on the Swedish SUPERB cohort of 2,081 community-dwelling women aged 75–80, and it is published in Nature Communications. Findings were examined for generalizability using an independent Chinese cohort of 1,448 older adults. The study analyzed gut microbiota profiles in relation to FMI and frailty-related clinical outcomes.

Higher FMI, indicating greater frailty and mortality risk, was associated with lower gut microbial diversity, fewer microbial genes, and reduced predicted functional capacity. These microbiome features were also linked to physical function, mortality, and fall-related injuries. The researchers identified 404 bacterial species significantly associated with FMI, many of which were replicated in the Chinese cohort, suggesting shared microbial signatures across settings.

According to the investigators, these results may help illuminate biological processes involved in frailty and aging. In the longer term, the knowledge could support approaches to identify older individuals at increased risk of adverse outcomes. The team emphasized that the work demonstrates associations rather than causation and that additional research is needed to determine whether gut microbiota changes contribute to frailty development or could be leveraged for preventive strategies.

“Our results show that the gut microbiota reflects key aspects of frailty in older adults. It is particularly interesting that several of the associations were replicated in an independent cohort from China, which reinforces the relevance of the findings,” said Marina Vilar Geraldi, a researcher at Sahlgrenska Academy, University of Gothenburg.

“Frailty is a complex condition, and our findings suggest that the gut microbiota may be an important part of the overall picture. The next step is to investigate whether these microbial patterns can aid in risk assessment or form the basis for future interventions,” said Mattias Lorentzon, Professor at the University of Gothenburg and Senior Consultant at Sahlgrenska University Hospital.

Related Links
Sahlgrenska Academy, University of Gothenburg


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Aspiration System
VACUSAFE
Electrolyte Analyzer
BKE-B
Automatic CLIA Analyzer
Shine i6000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: New findings demonstrate that anti-Müllerian hormone (AMH) may help identify which breast cancer patients are most likely to benefit from chemotherapy plus endocrine therapy (Image Credit: Shutterstock)

AMH Test Helps Predict Adjuvant Chemotherapy Benefit in Premenopausal Breast Cancer

Hormone receptor-positive, human epidermal growth factor receptor 2-negative (HR+/HER2-) breast cancer can present a difficult treatment decision in premenopausal patients with low recurrence scores.... Read more

Molecular Diagnostics

view channel
Image Credit: iStock

Sequencing-Based Newborn Screening Identifies Pediatric Cancer Risk at Birth

Newborn screening in the United States relies on heel-stick blood spots to identify rare, treatable disorders through biochemical testing, but these programs generally do not assess inherited cancer risk... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.